Fundraise / allotmentFiled on BSE ·
Manipal Health Enterprises redeems ₹5,310 crore debentures using IPO proceeds
Manipal Health Enterprises Ltd
What the filing says
- Utilised IPO proceeds for full redemption of outstanding non-convertible debentures
- Debentures issued by wholly owned subsidiary Manipal Hospitals Private Limited
- Redemption includes accrued interest and prepayment/early redemption costs as per IPO prospectus dated July 31, 2026
Original filing
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations')
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Manipal Health Enterprises Ltd
- Fundraise / allotmentManipal Hospitals redeems ₹5,310 crore NCDs using IPO proceeds in September 2026
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentMangalam Global Enterprise LtdMangalam Global Enterprise Limited approves issuance of NCDs worth up to ₹150 crore
- Fundraise / allotmentMangalam Global Enterprise LtdMangalam Global Enterprise Limited approves issuance of NCDs worth ₹150 crore
- Fundraise / allotmentRegency FincorpRegency Fincorp Limited announces preferential issue and ESOP proposal
- Fundraise / allotmentRegency FincorpRegency Fincorp approves ₹312.15 crore fundraise via equity and warrants
- Fundraise / allotmentRegency FincorpRegency Fincorp receives Board approval for ₹312.15 crore fundraise via equity and warrants
- Fundraise / allotmentSahana Systems LtdSahana System Limited approves preferential issue of warrants and director appointment
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.